18F-FDG PET imaging in assessing exudative pleural effusions

Background This study evaluates the accuracy of [18F]fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging with semi-quantitative analysis for differentiating benign from malignant pleural exudates and for guiding the search for the primary tumour of pleural metastases. Methods Whole-body 18F-FDG PET was performed in 79 patients with exudative pleurisy. Standard uptake values were normalized for body weight, body surface area, lean body mass (SUVbw, SUVbsa, SUVlbm) with and without correction for blood glucose levels. Thoracoscopy was systematically performed to reveal pathological diagnosis. Results All SUVs were significantly higher in all malignant pleural diseases (n=51) than in benign (n=28) (P<0.001). Moreover SUVs were greater in the pleural metastases from pulmonary primaries (n=25) and in mesotheliomas (n=8) than in extrathoracic primaries (n=18) (P<0.01) with no significant difference between lung cancers and mesotheliomas. Receiver operating curve (ROC) analysis between benign and malignant lesions showed areas under the curves that ranged from 0.803 (SUVbsa g−1) to 0.863 (SUVbw). The cut-off value for SUVbw which gave the best accuracy (82.3%) was 2.2. When comparing thoracic with extrathoracic primaries the highest accuracy (80.4%) was found for a cut-off value of 2.6. Conclusion Semi-quantitative analysis of 18F-FDG PET imaging helps to differentiate malignant from benign pleural exudates and to distinguish between thoracic or extrathoracic primaries.

[1]  U. Haberkorn Positron emission tomography in the diagnosis of mesothelioma. , 2004, Lung cancer.

[2]  H. Schoellnast,et al.  Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. , 2004, Radiology.

[3]  H. Groen,et al.  PET for the evaluation of pleural thickening observed on CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  R. Louis,et al.  Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. , 2004, Chest.

[5]  U. Waheed,et al.  Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. , 2002, Chest.

[6]  Y. Menda,et al.  Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy , 2001, Nuclear medicine communications.

[7]  S. Hain,et al.  Prognostic value of FDG PET imaging in malignant pleural mesothelioma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Rigo,et al.  Typical appearance of mesothelioma on an F-18 FDG positron emission tomograph. , 2000, Clinical nuclear medicine.

[9]  F. Fazio,et al.  18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  R. Coleman,et al.  FDG PET of pleural effusions in patients with non-small cell lung cancer. , 2000, AJR. American journal of roentgenology.

[11]  R L Wahl,et al.  Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. , 1999, Radiology.

[12]  R L Wahl,et al.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.

[13]  A. Alavi,et al.  Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. , 1998, Chest.

[14]  A. Dowlati,et al.  Evaluation of pleural diseases with FDG-PET imaging: preliminary report. , 1997, Thorax.

[15]  R R Miller,et al.  CT in differential diagnosis of diffuse pleural disease. , 1990, AJR. American journal of roentgenology.

[16]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[17]  S. Sahn,et al.  State of the art. The pleura. , 1988, The American review of respiratory disease.

[18]  C. Rhodes,et al.  Positron emission tomography in the lung , 1985, Journal of thoracic imaging.

[19]  S. Sahn Malignant Pleural Effusions , 1985, Clinics in chest medicine.

[20]  U. Prakash,et al.  Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. , 1985, Mayo Clinic proceedings.

[21]  T. McLoud,et al.  Computed tomography of localized pleural mesothelioma. , 1985, AJR. American journal of roentgenology.

[22]  M. Utell,et al.  Sensitivity, specificity, and predictive values of closed pleural biopsy. , 1984, Archives of internal medicine.

[23]  L. Koss,et al.  Comparison of the diagnostic values of biopsies of the pleura and cytologic evaluation of pleural fluids. , 1979, American journal of clinical pathology.

[24]  D. V. Von Hoff,et al.  Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies. , 1975, American journal of clinical pathology.

[25]  W. C. Ball,et al.  Cells in pleural fluid. Their value in differential diagnosis. , 1973, Archives of internal medicine.

[26]  W. C. Ball,et al.  Pleural effusions: the diagnostic separation of transudates and exudates. , 1972, Annals of internal medicine.

[27]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .